Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Gastroenterol Hepatol ; 41(7): 432-439, 2018.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-29895412

RESUMO

BACKGROUND: The use of stress ulcer prophylaxis (SUP) has risen in recent years, even in patients without a clear indication for therapy. AIM: To evaluate the efficacy of an electronic medical record (EMR)-based alarm to improve appropriate SUP use in hospitalized patients. METHODS: We conducted an uncontrolled before-after study comparing SUP prescription in intensive care unit (ICU) patients and non-ICU patients, before and after the implementation of an EMR-based alarm that provided the correct indications for SUP. RESULTS: 1627 patients in the pre-intervention and 1513 patients in the post-intervention cohorts were included. The EMR-based alarm improved appropriate (49.6% vs. 66.6%, p<0.001) and reduced inappropriate SUP use (50.4% vs. 33.3%, p<0.001) in ICU patients only. These differences were related to the optimization of SUP in low risk patients. There was no difference in overt gastrointestinal bleeding between the two cohorts. Unjustified costs related to SUP were reduced by a third after EMR-based alarm use. CONCLUSIONS: The use of an EMR-based alarm improved appropriate and reduced inappropriate use of SUP in ICU patients. This benefit was limited to optimization in low risk patients and associated with a decrease in SUP costs.


Assuntos
Alarmes Clínicos , Registros Eletrônicos de Saúde , Prescrição Inadequada/prevenção & controle , Úlcera Péptica Hemorrágica/diagnóstico , Úlcera Péptica/prevenção & controle , Antiulcerosos/uso terapêutico , Comorbidade , Custos e Análise de Custo , Antagonistas dos Receptores H2 da Histamina/uso terapêutico , Humanos , Pacientes Internados , Unidades de Terapia Intensiva , Úlcera Péptica/tratamento farmacológico , Úlcera Péptica Hemorrágica/prevenção & controle , Inibidores da Bomba de Prótons/uso terapêutico , Respiração Artificial , Risco , Centros de Atenção Terciária
2.
Artigo em Espanhol | MEDLINE | ID: mdl-24646932

RESUMO

Vertebroplasty is a minimally invasive technique for the treatment of osteoporotic fractures. Within its complications is pulmonary embolism, which can be asymptomatic or with respiratory distress and may be notes by radiography or computed tomography. At present there is no guide to indicate the routine performance of imaging techniques after treatment, and all agreed on the need to start anticoagulant therapy for 3 months or so with coumarin in symptomatic or asymptomatic central emboli.


La vertebroplastia representa una técnica mínimamente invasiva para el tratamiento de las fracturas osteoporóticas. Dentro de sus complicaciones se encuentra el embolismo pulmonar, el cuál puede cursar asintomático o con dificultad respiratoria, pudiendo ser constatado mediante radiografía o tomografía computada. En la actualidad no existen guías que indiquen la realización rutinaria de técnicas de imágenes posteriores a la vertebroplastia y en todas se acuerda en la necesidad de comenzar tratamiento anticoagulante por lo menos 3 meses aproximadamente con cumarínicos, en embolias sintomáticas o asintomáticas centrales .


Assuntos
Embolia Pulmonar/diagnóstico por imagem , Vertebroplastia/efeitos adversos , Anticoagulantes/uso terapêutico , Cimentos Ósseos/efeitos adversos , Feminino , Humanos , Pessoa de Meia-Idade , Osteoporose/complicações , Embolia Pulmonar/tratamento farmacológico , Embolia Pulmonar/etiologia , Radiografia
3.
Artigo em Espanhol | LILACS, BINACIS | ID: biblio-1170947

RESUMO

Vertebroplasty is a minimally invasive technique for the treatment of osteoporotic fractures. Within its complications is pulmonary embolism, which can be asymptomatic or with respiratory distress and may be notes by radiography or computed tomography. At present there is no guide to indicate the routine performance of imaging techniques after treatment, and all agreed on the need to start anticoagulant therapy for 3 months or so with coumarin in symptomatic or asymptomatic central emboli.


Assuntos
Embolia Pulmonar/diagnóstico por imagem , Vertebroplastia/efeitos adversos , Anticoagulantes/uso terapêutico , Cimentos Ósseos/efeitos adversos , Embolia Pulmonar/etiologia , Embolia Pulmonar/tratamento farmacológico , Feminino , Humanos , Osteoporose/complicações , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa